Sign in
4

Changes in Ownership

Dermata Therapeutics, Inc. Filed Acc 0000905718-22-000052

Options or other derivatives

  • Senior VP, Development acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nardo Christopher J. · Senior VP, Development

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 1 in the form Stock Option (right to buy) +30,000 30,000 D
Loading xslF345X03/dermata_fm4jan32022.xml…